4//SEC Filing
Cha Myoungil 4
Accession 0001438133-24-000127
CIK 0001438133other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 7:23 PM ET
Size
9.2 KB
Accession
0001438133-24-000127
Insider Transaction Report
Form 4
Cha Myoungil
Director
Transactions
- Exercise/Conversion
Common Stock
2024-05-24$51.73/sh+4,065$210,282→ 5,814 total - Exercise/Conversion
Restricted Stock Unit
2024-05-24−4,065→ 0 total→ Common Stock (4,065 underlying) - Award
Restricted Stock Unit
2024-05-22+4,387→ 4,387 total→ Common Stock (4,387 underlying)
Footnotes (4)
- [F1]Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
- [F2]Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F3]RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
- [F4]Awarded on May 24, 2023 pursuant to the 2023 Plan.
Documents
Issuer
TANDEM DIABETES CARE INC
CIK 0001438133
Entity typeother
Related Parties
1- filerCIK 0001934068
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 7:23 PM ET
- Size
- 9.2 KB